FDA Inspection 1097014 — Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd. — FEI 3002808385

The FDA completed an inspection of Taro Pharmaceutical Industries Ltd. on July 11, 2019 in Haifa Bay. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 11, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Haifa Bay (Israel)

Citations

IDCFRDescription
202821 CFR 211.192Extent of discrepancy, failure investigations